Spotlight On... EPFL team creates an industrial-scale platform for stem cells; Antibodies neutralize Ebola strains; New pathway for immune response; and more...

Scientists at the Ecole Polytechnique Fédérale de Lausanne say they have developed a new technique that uses a gel consisting of growth nutrients to "squeeze" cells into more malleable stem cells. This approach promises to create a new industrial-sized platform that can be used to manufacture large quantities of stem cells needed for a variety of applications. Release

> Researchers at Albert Einstein College of Medicine have created antibodies that were able to neutralize two of the most potent strains of Ebola in mice. Release

> Lung cells known as pulmonary neuroendocrine cells, or PNECs, can regulate an immune response, offering a new pathway for treating errant immune responses that cause diseases such as asthma. Release


Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.